参考文献/References:
[1] CHAKAYA J,KHAN M,NTOUMI F,et al.Global Tuberculosis Report 2020 - Reflections on the Global TB burden,treatment and prevention efforts[J].Int J Infect Dis,2021,113(Suppl 1):S7-S12.
[2] WALZL G,MCNERNEY R,PLESSIS N D,et al.Tuberculosis;advances and challenges in development of new diagnostics and biomarkers[J].Lancet Infect Dis,2018,18(7):e199-e210.
[3] CHEON S A,CHO H H,KIM J,et al.Recent tuberculosis diagnosis toward the end TB strategy[J].J Microbiol Methods,2016,123:51-61.
[4] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断标准(WS 288—2017)[J].新发传染病电子杂志,2018,3(1):59-61.
NATIONAL HEALTH AND FAMILY PLANNING COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA.Diagnostic criteria for tuberculosis[J].Electron J Emerg Infect Dis,2018,3(1):59-61.
[5] 何小珊,朱辉超,郭俊华.不同血清肿瘤标志物在抗结核治疗过程中的变化[J].基因组学与应用生物学,2017,36(11):4523-4527.
HE X S,ZHU H C,GUO J H.The change of different serum tumor markers in the process of anti-tuberculosis treatment[J].Genom Appl Biol,2017,36(11):4523-4527.
[6] NEWMAN A M,LIU C L,GREEN M R,et al.Robust enumeration of cell subsets from tissue expression profiles[J].Nat Methods,2015,12(5):453-457.
[7] 李慧月,王沐榛,喻叶,等.加权基因共表达网络分析筛选胰腺癌肿瘤免疫相关基因[J].华南师范大学学报(自然科学版),2021,53(6):61-67.
LI H Y,WANG M Z,YU Y,et al.Screening genes related with tumor immunity in pancreatic cancer with the WGCN analysis[J].J South China Norm Univ Nat Sci Ed,2021,53(6):61-67.
[8] 汪静,张惠斌,周金培,等.抗结核新靶点及相关药物的研究进展[J].中国药科大学学报,2012,43(1):1-8.
WANG J,ZHANG H B,ZHOU J P,et al.Advances in new anti-tuberculosis targets and related drugs[J].J China Pharm Univ,2012,43(1):1-8.
[9] BUSCH M,HERZMANN C,KALLERT S,et al.Lipoarabinomannan-responsive polycytotoxic T cells are associated with protection in human tuberculosis[J].Am J Respir Crit Care Med,2016,194(3):345-355.
[10] NG S S,DE LABASTIDA RIVERA F,YAN J,et al.The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation[J].Nat Immunol,2020,21(10):1205-1218.
[11] 王珏,张野,王磊,等.T-bet的生物学特性和研究进展[J].现代生物医学进展,2013,13(25):4995-4998.
WANG J,ZHANG Y,WANG L,et al.Biological characteristics of T-bet and its research progress[J].Prog Mod Biomed,2013,13(25):4995-4998.
[12] WU J,XU J,CAI C,et al.Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma[J].Respir Res,2009,10(1):51.
[13] MOREIRA-TEIXEIRA L,TABONE O,GRAHAM C M,et al.Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis[J].Nat Immunol,2020,21(4):464-476.
[14] 叶文凤,徐永娟,蒋敬庭.CD247与免疫相关疾病的研究进展[J].现代免疫学,2018,38(1):72-75.
YE W F,XU Y J,JIANG J T.Research progress of CD247 and immune-related diseases[J].Curr Immunol,2018,38(1):72-75.
[15] 高美华,钟丹丹,张蓓.CD59-CD2对T细胞信号转导的作用[J].免疫学杂志,2011,27(9):773-776,780.
GAO M H,ZHONG D D,ZHANG B.Roles of CD59 and CD2 in T cell signal transduction[J]. Immunol J,2011,27(9):773-776,780.
[16] 王瑜,王健.白细胞介素-2受体结构及信号传导[J].中国微生态学杂志,2005,17(5):399.
WANG Y,WANG J.Interleukin-2 receptor structure and signal transduction[J].Chin J Microecol,2005,17(5):399.
[17] 雷建平.结核病免疫治疗研究进展[C].//中华医学会2008年全国结核病学术会议论文汇编.长沙,2008:509-514.
LEI J P.Research progress of immunotherapy for tuberculosis[C].//Compilation of papers of the 2008 National tuberculosis Academic Conference,Chinese Medical Association.Changsha,2008:509-514.
[18] 吴雪琼,范琳.活动性结核病患者免疫功能状态评估和免疫治疗专家共识(2021年版)[J].中国防痨杂志,2022,44(1):9-27.
WU X Q,FAN L.Expert consensus on immune function assessment and immunotherapy in patients with active tuberculosis (2021 Edition)[J].Chin J Antituberc,2022,44(1):9-27.
[19] 齐花蕊,王春芳,钱爱东.Th17和Treg在结核分枝杆菌感染中的研究进展[J].中国预防兽医学报,2014,36(12):985-987.
QI H R,WANG C F,QIAN A D.Research progress of Th17 and Treg in Mycobacterium tuberculosis infection[J].Chin J Prev Vet Med,2014,36(12):985-987.
[20] 李沛军,莫晨玲,马秀珍.肺结核患者外周血Th17/Treg的表达及其病理意义[J].现代免疫学,2020,40(5):408-411.
LI P J,MO C L,MA X Z.Peripheral blood Th17/Treg ratio in patients with pulmonary tuberculosis and its pathological significance[J].Curr Immunol,2020,40(5):408-411.
[21] SUN X,LIU K,ZHAO Y,et al.High miRNA-378 expression has high diagnostic values for pulmonary tuberculosis and predicts adverse outcomes[J].BMC Mol Cell Biol,2022,23(1):14.
[22] 黄秀芳,钟利.结核病免疫治疗进展[J].国外医药(抗生素分册),2012,33(6):241-243,289.
HUANG X F,ZHONG L.The research of tuberculosis immunotherapy[J].World Notes Antibiot,2012,33(6):241-243,289.